This document lists 13 intermediates along with their CAS numbers, chemical structures, and potential end uses. The intermediates are used in a variety of therapeutic areas including cancer, atherosclerosis, restenosis, endometriosis, and psoriasis. They include compounds used in tyrosine kinase inhibitors, BACE1 inhibitors, crizotinib, palbociclib, maraviroc, and tebipenem among others. The contact information provided is for a company located in Visakhapatnam, India that synthesizes and supplies these pharmaceutical intermediates.